Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer

British Journal of Cancer

Volumn 74, Issue 1, 1996, Pages 141-144

  Castiglione, G ^a   Zappa, M ^a   Grazzini, G ^a   Mazzotta, A ^a   Biagini, M ^b   Salvadori, P ^c   Ciatto, S ^a  

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^b Endoscopy Unit   (Italy)

^c Dipartimento della Riabilitazione e Delle Fragilitá   (Italy)

Author keywords

Colorectal neoplasms diagnosis; Colorectal neoplasms prevention and control; Guaiac test; Immunochemical test; Occult blood

Indexed keywords

GUAIAC;

ADENOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HUMAN; IMMUNOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OCCULT BLOOD; PRIORITY JOURNAL;

EID: 0030037844     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.329     Document Type: Article

References (15)

1. CASTIGLIONE G, GRAZZINI G AND CIATTO S. (1992). Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening. Br. J. Cancer, 65, 942-944.
2. CASTIGLIONE G, SALA P, CIATTO S, GRAZZINI G., MAZZOTTA A, ROSSETTI C, SPINELLI P AND BERTARIO L. (1994). Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions. Eur. J. Cancer Prev., 3, 399-405.
3. DAY NE, WALTER SD, TABAR L, FAGERBERGER CJG AND COLETTE HJA. (1988). The Sensitivity and the Lead Time of Breast Cancer Screening: a Comparison of the Results in Different Studies (UICC publication), pp. 105-109. H Huber: Toronto.
4. LAZOVICH DA, WEISS NS, STEVENS NG, WHITE E, McKNIGHT B AND WAGNER EH (1995). A case-control study to evaluate efficacy of screening faecal occult blood. J. Med. Screening, 2, 84-89.
5. McNEMAR Q. (1947). Note on the sampling of the differences between corrected proportions and percentages. Psychometrica, 12, 153-157.
6. MANDEL JS, BOND JH, CHURCH TR, SNOVER DC, BRADLEY GM, SCHUMAN LM AND EDERER F. (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Met., 328, 1365-1371.
7. MANDEL JS, EDERER F, CHURCH TC AND BOND J. (1994). Screening for colorectal cancer: which test is best? JAMA, 272, 1099.
8. MORRISON AS. (1985). Screening in Chronic Diseases, pp. 60-62, 142-144. Oxford University Press: New York.
9. PETRELLI N, MICHALEK AM, FREEDMAN A, BARONI M, MINK I AND RODRIGUEZ-BIGAS M. (1994). Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. Surg. Oncol., 3, 27-36.
10. ROBINSON MHE, MARKS CG, FARRANDS PA, THOMAS WM AND HARDCASTLE JD. (1994). Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. Br. J. Surg., 81,448-451.
11. SAITO H, SOMA Y, KOEDA J, WADA T, KAWAGUCHI H, SOBUE T, AISAWA T AND YOSHIDA Y. (1995). Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int. J. Cancer, 61, 465-469.
12. SELBY JV, FRIEDMAN GD, QUESENBERRY CP AND WEISS NS (1993). Effect of fecal occult blood testing on mortality from colorectal cancer. A case control study. Ann. Intern. Med., 118, 1-6.
13. ST JOHN DJB, YOUNG GP, ALEXEYEFF MA, DEACON MC, CUTHBERTSON AM, MACRAE FA AND PFNFOLD JC. (1993). Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterologe, 104, 1661-1668.
14. WAHRENDORF J, ROBRA BP, WIEBELT H, OBERHAUSEN R, WIELAND M AND DHOM G. (1993). Effectiveness of colorectal cancer screening: Results from a population-based case-control evaluation in Saarland, Germany. Eur. J. Cancer Prev., 2, 221-227.
15. ZANETTI R AND CROSIGNANI P. (EDS). (1992). Cancer in Italy. Incidence Data from Cancer Registries (1983-87). Lega Italiana per la Lotta contro i Tumori Associazione Italiana di Epidemiologia: Turin.